127 related articles for article (PubMed ID: 33372800)
1. 3,4-Dihydropyrimidin-2(1
Majellaro M; Jespers W; Crespo A; Núñez MJ; Novio S; Azuaje J; Prieto-Díaz R; Gioé C; Alispahic B; Brea J; Loza MI; Freire-Garabal M; Garcia-Santiago C; Rodríguez-García C; García-Mera X; Caamaño O; Fernandez-Masaguer C; Sardina JF; Stefanachi A; El Maatougui A; Mallo-Abreu A; Åqvist J; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2021 Jan; 64(1):458-480. PubMed ID: 33372800
[TBL] [Abstract][Full Text] [Related]
2. Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A
Mallo-Abreu A; Prieto-Díaz R; Jespers W; Azuaje J; Majellaro M; Velando C; García-Mera X; Caamaño O; Brea J; Loza MI; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2020 Jul; 63(14):7721-7739. PubMed ID: 32573250
[TBL] [Abstract][Full Text] [Related]
3. A
Jiang J; Seel CJ; Temirak A; Namasivayam V; Arridu A; Schabikowski J; Baqi Y; Hinz S; Hockemeyer J; Müller CE
J Med Chem; 2019 Apr; 62(8):4032-4055. PubMed ID: 30835463
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Effect of Halogenation in a Series of Potent and Selective A
Prieto-Díaz R; González-Gómez M; Fojo-Carballo H; Azuaje J; El Maatougui A; Majellaro M; Loza MI; Brea J; Fernández-Dueñas V; Paleo MR; Díaz-Holguín A; Garcia-Pinel B; Mallo-Abreu A; Estévez JC; Andújar-Arias A; García-Mera X; Gomez-Tourino I; Ciruela F; Salas CO; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2023 Jan; 66(1):890-912. PubMed ID: 36517209
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
El Maatougui A; Azuaje J; González-Gómez M; Miguez G; Crespo A; Carbajales C; Escalante L; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2016 Mar; 59(5):1967-83. PubMed ID: 26824742
[TBL] [Abstract][Full Text] [Related]
6. Trifluorinated Pyrimidine-Based A
Mallo-Abreu A; Majellaro M; Jespers W; Azuaje J; Caamaño O; García-Mera X; Brea JM; Loza MI; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2019 Oct; 62(20):9315-9330. PubMed ID: 31557025
[TBL] [Abstract][Full Text] [Related]
7. Enantiospecific Recognition at the A
Carbajales C; Azuaje J; Oliveira A; Loza MI; Brea J; Cadavid MI; Masaguer CF; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2017 Apr; 60(8):3372-3382. PubMed ID: 28368607
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent-Labeled Selective Adenosine A
Köse M; Gollos S; Karcz T; Fiene A; Heisig F; Behrenswerth A; Kieć-Kononowicz K; Namasivayam V; Müller CE
J Med Chem; 2018 May; 61(10):4301-4316. PubMed ID: 29681156
[TBL] [Abstract][Full Text] [Related]
9. Exploring Biginelli-based scaffolds as A
Prieto-Díaz R; Fojo-Carballo H; Majellaro M; Tandarić T; Azuaje J; Brea J; Loza MI; Barbazán J; Salort G; Chotalia M; Rodríguez-Pampín I; Mallo-Abreu A; Rita Paleo M; García-Mera X; Ciruela F; Gutiérrez-de-Terán H; Sotelo E
Biomed Pharmacother; 2024 Apr; 173():116345. PubMed ID: 38442670
[TBL] [Abstract][Full Text] [Related]
10. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
[TBL] [Abstract][Full Text] [Related]
11. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
[TBL] [Abstract][Full Text] [Related]
12. 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists.
Taliani S; Pugliesi I; Barresi E; Simorini F; Salerno S; La Motta C; Marini AM; Cosimelli B; Cosconati S; Di Maro S; Marinelli L; Daniele S; Trincavelli ML; Greco G; Novellino E; Martini C; Da Settimo F
J Med Chem; 2012 Feb; 55(4):1490-9. PubMed ID: 22257095
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of endogenous A
Goulding J; May LT; Hill SJ
Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel xanthine derivatives as potent and selective A
Basu S; Barawkar DA; Ramdas V; Patel M; Waman Y; Panmand A; Kumar S; Thorat S; Naykodi M; Goswami A; Reddy BS; Prasad V; Chaturvedi S; Quraishi A; Menon S; Paliwal S; Kulkarni A; Karande V; Ghosh I; Mustafa S; De S; Jain V; Banerjee ER; Rouduri SR; Palle VP; Chugh A; Mookhtiar KA
Eur J Med Chem; 2017 Jul; 134():218-229. PubMed ID: 28415011
[TBL] [Abstract][Full Text] [Related]
15. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA
J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777
[TBL] [Abstract][Full Text] [Related]
16. New 8-substituted xanthiene derivatives as potent bronchodilators.
Berk B; Akgün H; Erol K; Sirmagül B; Gao ZG; Jacobson KA
Farmaco; 2005; 60(11-12):974-80. PubMed ID: 16243321
[TBL] [Abstract][Full Text] [Related]
17. Irreversible Antagonists for the Adenosine A
Temirak A; Schlegel JG; Voss JH; Vaaßen VJ; Vielmuth C; Claff T; Müller CE
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744918
[TBL] [Abstract][Full Text] [Related]
18. Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A
Vlachodimou A; de Vries H; Pasoli M; Goudswaard M; Kim SA; Kim YC; Scortichini M; Marshall M; Linden J; Heitman LH; Jacobson KA; IJzerman AP
Biochem Pharmacol; 2022 Jun; 200():115027. PubMed ID: 35395239
[TBL] [Abstract][Full Text] [Related]
19. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A
Falsini M; Squarcialupi L; Catarzi D; Varano F; Betti M; Dal Ben D; Marucci G; Buccioni M; Volpini R; De Vita T; Cavalli A; Colotta V
J Med Chem; 2017 Jul; 60(13):5772-5790. PubMed ID: 28590753
[TBL] [Abstract][Full Text] [Related]
20. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
